Frequency Therapeutics redesigns study after disappointing Phase 2 results, debuts new hearing loss and MS drugs
Published
Nov 09 2021 at 3:19 PM GMT
Key
Points
Points
- In Frequency Therapeutics" short lifetime as a company, it's had its ups and downs.
- On Tuesday, during an R&D event day, the company unleashed a slew of announcements that add context to the development of a flagship hearing loss drug, and propose some directions.
- Founded in 2015, Frequency Therapeutics has focused on a regenerative medicine.
-
Posted in Technology
Trending
Stats
- Published Nov 9, 2021 3:19 PM GMT